Presentation Information
[1P-870]DNA methylation and APOBEC cause acquisition of drug-resistance mutation in lung cancer
○Yosuke Seto1, Naoya Fujita2, Makoto Nishio3, Ryohei Katayama1 (1. Div. Exp. Chemother., Cancer Chemother. Ctr., JFCR, 2. Cancer Chemother. Ctr., JFCR, 3. Dept. Thorac. Med. Oncology, Cancer Inst. Hosp., JFCR)
Password required to view
orLog in
Comment
To browse or post comments, you must log in.Log in